Truvada Versus Truvada Plus Hepatitis B Immunoglobulin (HBIG) in Prevention of Chronic Hepatitis B Recurrence Post Liver Transplant
This study has been completed.
Sponsor:
Gilead Sciences
Information provided by (Responsible Party):
Gilead Sciences
ClinicalTrials.gov Identifier:
NCT00507689
First received: July 25, 2007
Last updated: May 18, 2012
Last verified: May 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | May 2011 |
| Primary Completion Date: | May 2011 (Final data collection date for primary outcome measure) |
| Certification or Request for Extension to Delay Results Received: | May 2, 2012 |